As AML cells failed to develop resistant clones under incubation with quziartinib plus the CDK4 inhibitor PD0332991, a dual FLT3/CDK4 inhibitor AMG 925 came up and was demonstrated to overcome FLT3 inhibitor resistance.260. The gene discussed is FLT3; the disease is acute myeloid leukemia.